Perrigo Company (NYSE:PRGO) EVP Jeffrey Needham sold 3,595 shares of the business’s stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of $89.49, for a total transaction of $321,716.55. Following the sale, the executive vice president now directly owns 10,118 shares of the company’s stock, valued at $905,459.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of Perrigo Company (NYSE PRGO) traded down 0.13% on Thursday, reaching $88.89. 884,538 shares of the company were exchanged. The company’s 50-day moving average price is $77.25 and its 200 day moving average price is $73.22. The company’s market cap is $12.68 billion. Perrigo Company has a 12 month low of $63.68 and a 12 month high of $99.14.

Perrigo (NYSE:PRGO) last released its quarterly earnings results on Thursday, August 10th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.28. The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.18 billion. Perrigo had a negative net margin of 51.04% and a positive return on equity of 11.55%. Perrigo’s revenue for the quarter was down 7.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.93 EPS. On average, equities research analysts expect that Perrigo Company will post $4.58 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 25th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Wednesday, August 23rd. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.72%. Perrigo’s dividend payout ratio is currently -3.51%.

WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/14/perrigo-company-prgo-evp-sells-321716-55-in-stock.html.

A number of research firms recently weighed in on PRGO. Deutsche Bank AG boosted their price target on shares of Perrigo from $88.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday. Royal Bank Of Canada reissued a “sell” rating and set a $64.00 price target on shares of Perrigo in a research note on Wednesday. Canaccord Genuity reissued a “buy” rating and set a $100.00 price target (up from $88.00) on shares of Perrigo in a research note on Wednesday. Cantor Fitzgerald boosted their price target on shares of Perrigo from $93.00 to $107.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, BidaskClub raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research note on Saturday, September 9th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have issued a buy rating to the company. Perrigo currently has an average rating of “Hold” and an average price target of $89.36.

Institutional investors have recently added to or reduced their stakes in the company. Korea Investment CORP raised its holdings in shares of Perrigo by 142.0% during the 2nd quarter. Korea Investment CORP now owns 1,331 shares of the company’s stock valued at $101,000 after purchasing an additional 781 shares in the last quarter. Commonwealth Bank of Australia raised its holdings in shares of Perrigo by 13.8% during the 2nd quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock valued at $108,000 after purchasing an additional 176 shares in the last quarter. Johnson Financial Group Inc. raised its holdings in shares of Perrigo by 15.6% during the 1st quarter. Johnson Financial Group Inc. now owns 1,775 shares of the company’s stock valued at $118,000 after purchasing an additional 240 shares in the last quarter. Global X Management Co. LLC raised its holdings in shares of Perrigo by 56.4% during the 1st quarter. Global X Management Co. LLC now owns 2,370 shares of the company’s stock valued at $157,000 after purchasing an additional 855 shares in the last quarter. Finally, Bessemer Group Inc. raised its holdings in shares of Perrigo by 1,046.2% during the 2nd quarter. Bessemer Group Inc. now owns 2,235 shares of the company’s stock valued at $169,000 after purchasing an additional 2,040 shares in the last quarter. Institutional investors and hedge funds own 80.36% of the company’s stock.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Insider Buying and Selling by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.